Recruiting

Observational Study

Sponsor:

Minneapolis Heart Institute Foundation

Code:

NCT05100940

Conditions

Coronary Artery Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Cardiac Catheterization

Study Details

Brief summary:

Coronary angiography and percutaneous coronary intervention (PCI) is often performed in patients with ischemic heart disease. The safety of PCI has improved with new devices and strategies, but complications still occur, especially during complex procedures. The objectives of this multi-center observational registry are to examine frequency of complications occuring during cardiac catheterization and PCI, examine procedural strategies utilized for complication management, and evaluate the clinical outcomes (both immediate and during follow-up.)

Conditions

Coronary Artery Disease

Study ID

NCT05100940

Start date

Nov 24, 2020

Status verified date

Aug, 2026

Completion date

Dec 31, 2030

Anticipated

Primary completion date

Dec 31, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

  • Over 18 years of age
  • undergoing coronary angiography or PCI
  • A complication occurred during or after the procedure

Study Design

Enrollment

4000 participants

Anticipated

Interventions and Outcome Measures

Interventions

Cardiac Catheterization

Cardiac Catheterization

Primary outcome measure

  • in-hospital major cardiac adverse events (MACE) [ Time Frame: From Date of Procedure to Date of Hospital Discharge, approximately 48-72 hrs after index procedure ]
  • Technical Success of PCI [ Time Frame: From Date of Procedure to Date of Hospital Discharge, approximately 48-72 hrs after index procedure ]
  • Procedural success of PCI [ Time Frame: From Date of Procedure to Date of Hospital Discharge, approximately 48-72 hrs after index procedure ]

Central Contacts and Locations

Central contacts

Emmanouil Brilakis, MD, PhD

612-863-3852emmanouil.brilakis@allina.com

Bavana Rangan, BDS, MPH

612-863-3833bavana.rangan@allina.com

Locations

Minneapolis Heart Institute Foundation

Recruiting

Minneapolis, Minnesota, United States, 55407

Contacts

Bavana V Rangan, BDS, MPH

817-821-9945bavana.rangan@allina.com

More Information

Sponsor

Minneapolis Heart Institute Foundation

Last update posted

Aug 19, 2026

Last verified

Aug, 2026

Keywords

  • complications
  • Percutaneous Coronary intervention

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Minneapolis Heart Institute Foundation on 2026-08-19.